keyword
MENU ▼
Read by QxMD icon Read
search

Recurrence-free survival

keyword
https://www.readbyqxmd.com/read/27933680/primary-breast-angiosarcoma-a-retrospective-study-of-36-cases-from-a-single-chinese-medical-institute-with-clinicopathologic-and-radiologic-correlations
#1
Lei Wang, I Weng Lao, Lin Yu, Wentao Yang, Jian Wang
The aim of this study was to present our experience with primary breast angiosarcoma (PBA) by describing a large series of cases with an emphasis on clinicopathologic and radiologic correlations. Thirty-six cases of PBA diagnosed at our institution between 2006 and 2014 were retrospectively evaluated. All but one case occurred in women with a median age of 35.5 years. The majority of patients presented with a deeply located painless mass, whereas a minority manifested as diffuse enlargement or swelling of the breast...
December 9, 2016: Breast Journal
https://www.readbyqxmd.com/read/27933239/impact-of-bowel-resection-margins-in-node-negative-colon-cancer
#2
Ricardo Rocha, Rui Marinho, David Aparício, Marta Fragoso, Marta Sousa, António Gomes, Carlos Leichsenring, Carla Carneiro, Vasco Geraldes, Vítor Nunes
PURPOSE: Surgical intestinal resection margins in colon cancer are a longstanding debate in terms the optimal distance between the tumor and the colonic section line. The aim of this study is to define the oncological outcomes in relation to surgical margins, measured in terms or recurrence rate, time-to-recurrence, disease-free survival and overall survival in a population of node negative colon cancer patients. METHODS: We conducted a retrospective observational longitudinal single institution study...
2016: SpringerPlus
https://www.readbyqxmd.com/read/27932270/prognostic-value-of-lymph-node-yield-during-nephroureterectomy-for-upper-tract-urothelial-carcinoma
#3
Andrew G Winer, Emily A Vertosick, Mazyar Ghanaat, Renato B Corradi, Sigrid Carlsson, Daniel D Sjoberg, Alexander I Sankin, John P Sfakianos, Eugene K Cha, Guido Dalbagni, Jonathan A Coleman
INTRODUCTION: Lymph node dissection (LND) performed during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) remains controversial and difficult to evaluate. The aim of this study was to investigate whether removal of more lymph nodes during RNU is safe and improves oncologic outcomes. METHODS: We evaluated 422 patients who underwent RNU with concomitant LND for upper tract urothelial carcinoma between 1976 and 2015, assessing for an association between total nodes removed, recurrence-free survival, and cancer-specific survival using Cox proportional hazards models...
December 5, 2016: Urologic Oncology
https://www.readbyqxmd.com/read/27932269/the-presence-of-carcinoma-in-situ-at-radical-cystectomy-increases-the-risk-of-urothelial-recurrence-implications-for-follow-up-schemes
#4
Marco Moschini, Shahrokh F Shariat, Mohammad Abufaraj, Francesco Soria, Tobias Klatte, Giovanni La Croce, Agostino Mattei, Rocco Damiano, Andrea Salonia, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Andrea Gallina
INTRODUCTION: To evaluate the incidence of carcinoma in situ (CIS) in patients treated with radical cystectomy (RC) due to bladder cancer and to assess its effect on recurrence and survival rates. METHODS: The study focused on 1,128 consecutive nonmetastatic patients with bladder cancer treated with RC at a single tertiary care referral center from 1994 to 2014. The Kaplan-Meier method was used to compare recurrence, cancer-specific mortality (CSM), and overall mortality-free rates in the overall population and in pT0-pT2 and pT3-pT4 patients after stratifying according to the presence of CIS...
December 5, 2016: Urologic Oncology
https://www.readbyqxmd.com/read/27932121/up-to-7-criteria-for-hepatocellular-carcinoma-liver-transplantation-a-retrospective-analysis-of-experiences
#5
F J León Díaz, J A Pérez Daga, B Sánchez Pérez, J L Fernández Aguilar, C Montiel Casado, J M Aranda Narváez, M A Suárez Muñoz, L Romacho López, J Santoyo Villalba, J Santoyo Santoyo
INTRODUCTION: The expansion of criteria for hepatocellular carcinoma (HCC) liver transplantation should produce satisfactory outcomes in terms of survival and recurrence. OBJECTIVES: To investigate if the up-to-7 criteria are applicable to liver transplantation for HCC. METHODS: A review of all liver transplantations performed at our unit between January 2002 and December 2010 was conducted (645 patients). The 91 patients of the sample who had HCC were divided into 3 groups: in Milan criteria (MC; n = 74), in up-to-7 criteria (UTSC; n = 12), and outside of up-to-7 criteria (OUTSC; n = 5)...
November 2016: Transplantation Proceedings
https://www.readbyqxmd.com/read/27932120/prognostic-value-of-pre-transplantation-serum-alpha-fetoprotein-levels-in-hepatocellular-carcinoma-recurrence
#6
E M Montalvá, M Cantos, A Boscà, A Rubín, C Vinaixa, P Granero, J Maupoey, R López-Andújar
Serum alpha-fetoprotein (AFP) value is still not included in the consensus guidelines to make decisions referring to liver transplantation (LT) for hepatocellular carcinoma (HCC). Many studies demonstrated the influence of high AFP level in poor prognosis after LT for HCC. We studied 301 consecutive recipients transplanted for HCC from January 2002 to December 2011. The median follow-up was 64.3 months (interquartile range, 41.6-90.8). HCC recurrence was 31.6% when AFP was >400 ng/mL and 50% when AFP was >1,000 ng/mL...
November 2016: Transplantation Proceedings
https://www.readbyqxmd.com/read/27932117/risk-factors-of-recurrence-of-diabetic-nephropathy-in-renal-transplants
#7
B Rodriguez Cubillo, B Rodriguez, M Calvo, V de la Manzanara, J Bautista, I Perez-Flores, N Calvo, A Moreno, A Shabaka, J Delgado, A I Sanchez-Fructuoso
BACKGROUND: Renal transplantation has been established as the treatment of choice for end-stage renal disease (ESRD) due to diabetic nephropathy. This study aimed to investigate the risk factors for recurrence of diabetic nephropathy (RDN) in renal allografts. METHODS: We studied 1,011 renal transplant patients from 1986 to 2003, of which 95 had ESRD due to diabetic nephropathy. We retrospectively analyzed the clinical characteristics and outcomes of RDN after renal transplantation...
November 2016: Transplantation Proceedings
https://www.readbyqxmd.com/read/27931751/phase-ii-study-of-irinotecan-in-combination-with-bevacizumab-in-recurrent-ovarian-cancer
#8
Fernanda Musa, Bhavana Pothuri, Stephanie V Blank, Huichung T Ling, James L Speyer, John Curtin, Leslie Boyd, Xiaochun Li, Judith D Goldberg, Franco Muggia, Amy Tiersten
OBJECTIVES: To evaluate the efficacy and safety of irinotecan and bevacizumab in recurrent ovarian cancer. The primary objective was to estimate the progression free survival (PFS) rate at 6months. Secondary objectives included estimation of overall survival (OS), objective response rate (ORR), duration of response, and an evaluation of toxicity. METHODS: Recurrent ovarian cancer patients with no limit on prior treatments were eligible. Irinotecan 250mg/m2 (amended to 175mg/m2 after toxicity assessment in first 6 patients) and bevacizumab 15mg/kg were administered every 3weeks until progression or toxicity...
December 5, 2016: Gynecologic Oncology
https://www.readbyqxmd.com/read/27931576/development-and-applicability-of-the-a-p-200-criteria-for-liver-transplantation-for-hepatocellular-carcinoma
#9
K Yang, T B Lee, B H Choi, Y M Park, J H Ryu, D J Joo, C W Chu
BACKGROUND: The Milan criteria are widely accepted for indicating liver transplantation in patients with hepatocellular carcinoma (HCC). However, a 7% to 20% possibility of HCC recurrence remains, even among patients who fulfill the Milan criteria. METHODS: We retrospectively reviewed 88 patients with HCC who underwent liver transplantation at Pusan National University Yangsan Hospital between May 2010 and December 2014. The risk factors for HCC recurrence were analyzed, and the overall survival and disease-free survival rates were calculated based on each risk factor...
December 2016: Transplantation Proceedings
https://www.readbyqxmd.com/read/27931221/the-patterns-and-timing-of-recurrence-after-curative-resection-for-gastric-cancer-in-china
#10
Dan Liu, Ming Lu, Jian Li, Zuyao Yang, Qi Feng, Menglong Zhou, Zhen Zhang, Lin Shen
BACKGROUND: The recurrence of gastric cancer after curative resection had adverse effects on patients' survival. The treatment presence varied from different countries. The aims of this study were to understand the recurrence incidence, patterns, and timing and to explore the risk factors in China. METHODS: One thousand three hundred four patients who undergoing curative resection from more than 100 hospitals between January 1st 1986 and September 1st 2013, were surveyed in detail...
December 8, 2016: World Journal of Surgical Oncology
https://www.readbyqxmd.com/read/27930642/adjuvant-treatment-for-renal-cell-carcinoma-do-we-finally-have-a-major-breakthrough
#11
Devin N Patel, Robert A Figlin, Hyung L Kim
Clinical parameters can be used to identify patients at greatest risk for recurrence following nephrectomy for clinically localized renal cell carcinoma (RCC). Molecular tools are being developed to improve risk stratification. An increasing list of available treatments for metastatic RCC continues to provide hope that an effective adjuvant therapy will be identified for patients with high-risk, clinically localized disease. In a phase 3 adjuvant therapy trial (S-TRAC), sunitinib increased median disease-free survival in patients with clear cell RCC who were at very high risk...
November 2016: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/27930549/prognostic-value-of-the-lymphocyte-monocyte-ratio-in-patients-with-colorectal-cancer-a-meta-analysis
#12
Wei Song, Kai Wang, Run-Jin Zhang, Shu-Bing Zou
BACKGROUND: Inflammation plays a critical role in the pathogenesis and progression of cancer. A low lymphocyte-to-monocyte ratio (LMR) is reported be a poor prognostic factor in multiple malignancies. We performed a meta-analysis to evaluate the prognostic role of preoperative LMR in colorectal cancer (CRC). METHODS: Studies investigating the prognostic role of preoperative LMR on survival in patients with CRC were systematically searched for in MEDLINE, EMBASE, Cochrane databases from inception up to August 2016...
December 2016: Medicine (Baltimore)
https://www.readbyqxmd.com/read/27928802/-clinical-characteristics-and-prognosis-analysis-of-119-cases-with-giant-gastrointestinal-stromal-tumor
#13
Peng Zhang, Xiangyu Zeng, Jinbo Gao, Weizhen Liu, Xiaoming Shuai, Ke Liu, Xinghua Liu, Ming Cai, Kailin Cai, Guobin Wang, Kaixiong Tao
OBJECTIVE: To investigate the clinical characteristics, diagnosis and treatment as well as prognostic factors of the giant gastrointestinal stromal tumor (GIST). METHODS: Clinical data of 235 patients with high risk GIST treated in the Union Hospital, Tongi Medical College, Huazhong University of Science and Technology between January 2005 and July 2015 were retrospectively analyzed. Patients were divided into giant GIST group (diameter equal to or larger than 10 cm, 119 cases) and high risk group (diameter less than 10 cm, 116 cases) according to tumor size...
November 25, 2016: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/27928801/-efficacy-observation-on-imatinib-reintroduction-in-gastrointestinal-stromal-tumor-with-high-recurrence-risk-after-imatinib-adjuvant-therapy-failure
#14
Zhi Dong, Jing Gao, Jifang Gong, Jie Li, Yan Li, Xicheng Wang, Yanyan Li, Lin Shen, Jian Li
OBJECTIVE: To evaluate the feasibility of imatinib reintroduction in gastrointestinal stromal tumor(GIST) with high recurrence risk after imatinib adjuvant therapy failure. METHODS: Clinical and follow-up data of 24 recurrent GIST patients with high recurrence risk receiving imatinib standard dose reintroduction(400 mg/d or 600 mg/d) after stopping imatinib adjuvant treatment more than 3 months in Department of GI Oncology of Peking University Cancer Hospital from August 2005 to January 2016 were retrospectively analyzed...
November 25, 2016: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/27928800/-efficacy-analysis-of-targeted-therapy-combined-with-surgery-in-the-treatment-of-recurrent-and-metastatic-gastrointestinal-stromal-tumor
#15
Xiaodong Gao, Anwei Xue, Yong Fang, Ping Shu, He Li, Jiaqian Ling, Li Wang, Yingyong Hou, Kuntang Shen, Jing Qin, Yihong Sun, Xinyu Qin
OBJECTIVE: To investigate the efficacy of targeted therapy combined with surgery in the treatment of recurrent and metastatic gastrointestinal stromal tumor(GIST). METHODS: Clinicopathological and followed-up data of 318 patients with recurrent and metastatic GIST admitted in Zhongshan Hospital between January 2000 and December 2015 were analyzed retrospectively. According to different treatment methods, the patients were divided into four groups: surgery group (operation alone, 44 cases), target therapy group (imatinib alone, 108 cases), target therapy combined with surgery group (imatinib plus operation, 139 cases), other therapy group (chemotherapy, Chinese medicine and others, 27 cases)...
November 25, 2016: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/27928795/-assessment-value-of-preoperative-platelet-lymphocyte-ratio-in-the-prognosis-of-patients-with-gastric-mixed-adenoneuroendocrine-carcinoma
#16
Longlong Cao, Jun Lu, Jianxian Lin, Chaohui Zheng, Ping Li, Jianwei Xie, Jiabin Wang, Qiyue Chen, Mi Lin, Ruhong Tu, Changming Huang
OBJECTIVE: To explore the prognostic assessment value of preoperative blood platelet-lymphocyte ratio (PLR) in patients with gastric mixed adenoneuroendocrine carcinoma (gMANEC) treated with radical surgery. METHODS: Clinical and pathological data of 84 gMANEC patients who underwent radical resection from 2006 to 2016 in Department of Gastric Surgery, Fujian Medical University Union Hospital were analyzed retrospectively. Receiver operating characteristic (ROC) curve analysis was performed to determine the cutoff value of the PLR for predicting prognosis...
November 25, 2016: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/27928787/-lancet-in-the-era-of-targeted-drug-therapy-the-role-of-surgery-in-the-management-of-advanced-gastrointestinal-stromal-tumor
#17
Hui Cao, Ming Wang
Gastrointestinal stromal tumor(GIST) is the most common mesenchymal tumor in the gastrointestinal tract. Due to the occult onset, GIST may present as local advanced or with metastatic disease at diagnosis. Imatinib mesylate (IM) has effectively improved the prognosis of GIST patients and has been established as principle therapy in metastatic GIST. The role of IM as an adjunction to surgery in the management of high-risk and local advanced GIST is also highly regarded. The role of surgery in metastatic or recurrent GIST is still a controversial clinic problem...
November 25, 2016: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/27928598/the-role-of-adjuvant-therapy-after-r0-resection-for-patients-with-intrahepatic-and-perihilar-cholangiocarcinomas
#18
Young Saing Kim, Sung Yong Oh, Se-Il Go, Jung-Hun Kang, Inkeun Park, Haa-Na Song, Jun Ho Ji, In Gyu Hwang, Joung-Soon Jang
PURPOSE: There is still debated regarding the optimal treatment strategy for cholangiocarcinoma (CC) after curative resection. The aim of this study was to analyze the role of adjuvant therapy in R0-resected intrahepatic and perihilar CCs. METHODS: We retrospectively reviewed the patients who underwent R0 resection for intrahepatic and perihilar CCs between January 2001 and December 2013 at six tertiary medical centers; adjuvant therapy consisted of chemotherapy (CT), chemoradiotherapy (CRT), or radiotherapy (RT)...
December 7, 2016: Cancer Chemotherapy and Pharmacology
https://www.readbyqxmd.com/read/27928453/impact-of-gender-and-primary-tumor-location-on-outcome-of-patients-with-cutaneous-melanoma
#19
Voinea S, Blidaru A, Panaitescu E, Sandru A
Background. The survival of patients with cutaneous malignant melanoma (MM) depends on multiple factors whose role is continuously updated, as the molecular mechanisms underlying the disease progression are understood. This study intended to assess whether the patient's gender and tumor location affect the disease outcome. Methods. Between 2008 and 2012, 155 patients with cutaneous MM underwent various types of surgeries in our clinic. Patients were staged according to the 2009 TNM classification. There were 90 women and 65 men...
October 2016: Journal of Medicine and Life
https://www.readbyqxmd.com/read/27928440/a-rare-case-of-metastasized-non-functional-pancreatic-neuroendocrine-tumor-with-a-good-long-term-survival
#20
Mirică A, Bădărău Ia, Mirică R, Păun S, Păun Dl
Background: Non-functional neuroendocrine tumors of the pancreas (NF-pNETs) are a varied group of extremely rare malignancies. The majority of patients already have liver metastases at the diagnosis moment, thus, treatment options are restricted, and the survival rate is reserved. Case report: We presented the case of 59-year-old patient, diagnosed with non-functional well-differentiated pancreatic neuroendocrine tumor grade II (NET G2) with the presence of chromogranin A, synaptophysin and somatostatin receptor 2, together with liver and bone metastases...
October 2016: Journal of Medicine and Life
keyword
keyword
119234
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"